CND Life Sciences, Inc.

Form D Filings

Location
Scottsdale, AZ
Industry Group
Biotechnology
Entity Type
Corporation
CIK
0001841099
All SEC Filings
View on sec.gov
Date Filed Security Types Amount Sold Diff Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
4/14/2025 Equity $150,000 $3,664,565 $9,000,000 $5,335,435 2/28/2025 4/14/2025 D/A 000184109925000003
3/6/2025 Equity $3,514,565 $3,514,565 $7,500,000 $3,985,435 2/28/2025 3/6/2025 D 000184109925000001
3/27/2024 Equity $2,007,000 $2,007,000 $6,000,000 $3,993,000 3/20/2024 3/27/2024 D 000184109924000001
7/24/2023 Debt, Security to be Acquired $1,457,000 $1,457,000 $1,457,000 $0 7/14/2023 7/24/2023 D 000184109923000002
3/24/2023 Equity $1,955,000 $4,500,000 $4,500,000 $0 9/16/2022 3/24/2023 D/A 000184109923000001
9/22/2022 Equity $2,545,000 $2,545,000 $4,000,000 $1,455,000 9/16/2022 9/22/2022 D 000184109922000001
11/10/2021 Equity $4,200,000 $4,200,000 $5,000,000 $800,000 10/29/2021 11/10/2021 D 000184109921000004
4/28/2021 Equity $2,050,000 $2,875,000 $2,875,000 $0 1/5/2021 4/28/2021 D/A 000184109921000003
1/20/2021 Equity $825,000 $825,000 $2,500,000 $1,675,000 1/5/2021 1/19/2021 D 000184109921000001